Amit Maya, Berisio Rita, Baram David, Harms Joerg, Bashan Anat, Yonath Ada
Department of Structural Biology, The Weizmann Institute, 76100 Rehovot, Israel.
FEBS Lett. 2005 Jun 13;579(15):3207-13. doi: 10.1016/j.febslet.2005.03.023. Epub 2005 Mar 23.
RNA protection experiments and the crystal structure of a complex of the large ribosomal subunit from the eubacterium Deinococcus radiodurans with rapamycin, a polyketide compound resembling macrolides and ketolides, showed that rapamycin binds to a crevice located at the boundaries of the nascent protein exit tunnel, near its entrance. At this location rapamycin cannot occlude the ribosome exit tunnel, consistent with its failure to act as a ribosomal antibiotic drug. In accord with recent biochemical data, this crevice may play a role in facilitating local cotranslational folding of nascent chains, in particular for transmembrane proteins.
RNA保护实验以及嗜放射栖热菌的大核糖体亚基与雷帕霉素(一种类似于大环内酯类和酮内酯类的聚酮化合物)复合物的晶体结构表明,雷帕霉素结合在新生蛋白质出口通道边界处靠近其入口的一个裂隙中。在这个位置,雷帕霉素无法堵塞核糖体出口通道,这与其不能作为核糖体抗生素药物的情况一致。与最近的生化数据相符,这个裂隙可能在促进新生链的局部共翻译折叠中发挥作用,特别是对于跨膜蛋白。